Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Pharm-NJ
    Registered Vendor
    • Nov 2010
    • 1

    #1

    Senior Research Scientist

    We are looking for a senior bioinformatics scientist to join Merck at our NJ site. You will be part of our matrix team to perform sophisticated data analysis, especially on next generation sequencing data, to support various drug discovery programs.

    Essential qualifications include:

    • PhD in biostatistics, computational biology, bioinformatics, math or similar field.
    • Experience in analyzing very large and complex data sets.
    • Experience in analyzing next generation sequencing data and microarray data.
    • Strong statistical and computational skills.
    • Has sufficient understanding of biology.

    If you are interested, please send your CV to [email protected] for consideration.

    Merck is an equal opportunity employer. For more information about Merck, please check http://www.merck.com/

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...